w 7 has been researched along with mevalonolactone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buddecke, E; Filipovic, I | 1 |
| Lehner, R; Rasouli, M; Trischuk, TC | 1 |
2 other study(ies) available for w 7 and mevalonolactone
| Article | Year |
|---|---|
Calmodulin antagonists stimulate LDL receptor synthesis in human skin fibroblasts.
Topics: 1-Methyl-3-isobutylxanthine; Acetates; Acetic Acid; Androstenes; Calcium Chloride; Calmodulin; Cholera Toxin; Cholesterol; Cyclic AMP; Fibroblasts; Humans; Hydroxycholesterols; Lovastatin; Methionine; Mevalonic Acid; Molecular Weight; Naphthalenes; p-Methoxy-N-methylphenethylamine; Receptors, LDL; Skin; Sulfonamides; Trifluoperazine | 1986 |
Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes.
Topics: Animals; Apolipoproteins B; Calmodulin; Carbon Radioisotopes; Cholesterol; Glycerides; Hepatocytes; Lipoproteins, VLDL; Mevalonic Acid; Oleic Acid; Rats; Sulfonamides; Tritium | 2004 |